UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by KFG Wealth Management LLC

KFG Wealth Management LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,005 shares of the healthcare conglomerate’s stock after selling 36 shares during the period. KFG Wealth Management LLC’s holdings in UnitedHealth Group were worth $529,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in UNH. Kraft Davis & Associates LLC grew its holdings in UnitedHealth Group by 3.4% during the 3rd quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock valued at $294,000 after purchasing an additional 19 shares in the last quarter. Iron Horse Wealth Management LLC grew its holdings in UnitedHealth Group by 1.6% during the 3rd quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock valued at $614,000 after purchasing an additional 19 shares in the last quarter. Secure Asset Management LLC grew its holdings in UnitedHealth Group by 0.8% during the 3rd quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock valued at $1,238,000 after purchasing an additional 19 shares in the last quarter. Bensler LLC grew its holdings in UnitedHealth Group by 0.3% during the 3rd quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock valued at $3,677,000 after purchasing an additional 19 shares in the last quarter. Finally, Texas Capital Bancshares Inc TX grew its holdings in UnitedHealth Group by 1.1% during the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after purchasing an additional 19 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday. Stephens reiterated an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Barclays raised their price target on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Truist Financial restated a “buy” rating and issued a $600.00 price target on shares of UnitedHealth Group in a research report on Wednesday. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $570.05.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

UnitedHealth Group Price Performance

Shares of UNH traded up $8.11 during mid-day trading on Friday, hitting $501.29. The company’s stock had a trading volume of 6,616,632 shares, compared to its average volume of 4,553,088. The firm has a 50-day moving average price of $488.97 and a 200 day moving average price of $515.22. The stock has a market capitalization of $462.16 billion, a price-to-earnings ratio of 30.63, a PEG ratio of 1.31 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same quarter in the previous year, the business earned $6.26 earnings per share. The firm’s revenue was up 8.6% compared to the same quarter last year. On average, research analysts predict that UnitedHealth Group Incorporated will post 27.74 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.50%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is presently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.